Evidence map›Paper›PMID 30428014›Full record

ArticleDNA research : an international journal for rapid publication of reports on genes and genomes2019

3' Branch ligation: a novel method to ligate non-complementary DNA to recessed or internal 3'OH ends in DNA or RNA.

Lin Wang, Yang Xi, Wenwei Zhang, Weimao Wang, Hanjie Shen, Xiaojue Wang, Xia Zhao, Andrei Alexeev, Brock A Peters, Alayna Albert and 11 more

Open access · goldAbstract read
In one paragraph

Article in DNA research : an international journal for rapid publication of reports on genes and genomes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. A well-designed bridge probe with dual functions of recognition and transduction towards a universal LAMP system.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 2 countries.

Lin WangAdvanced Genomics Technology Lab, Complete Genomics Inc., 2904 Orchard Pkwy, San Jose, California, USA.
Yang XiInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Wenwei ZhangInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Weimao WangInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Hanjie ShenInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Xiaojue WangInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Xia ZhaoInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Andrei AlexeevAdvanced Genomics Technology Lab, Complete Genomics Inc., 2904 Orchard Pkwy, San Jose, California, USA.
Brock A PetersInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Alayna AlbertAdvanced Genomics Technology Lab, Complete Genomics Inc., 2904 Orchard Pkwy, San Jose, California, USA.
Xu XuInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Han RenInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Ou WangInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Killeen KirkconnellAdvanced Genomics Technology Lab, Complete Genomics Inc., 2904 Orchard Pkwy, San Jose, California, USA.
Helena PerazichAdvanced Genomics Technology Lab, Complete Genomics Inc., 2904 Orchard Pkwy, San Jose, California, USA.
Sonya ClarkAdvanced Genomics Technology Lab, Complete Genomics Inc., 2904 Orchard Pkwy, San Jose, California, USA.
Evan HurowitzAdvanced Genomics Technology Lab, Complete Genomics Inc., 2904 Orchard Pkwy, San Jose, California, USA.
Ao ChenInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Xun XuInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Radoje DrmanacInstitute of Biochemistry, BGI-Shenzhen, Shenzhen, China.
Yuan JiangAdvanced Genomics Technology Lab, Complete Genomics Inc., 2904 Orchard Pkwy, San Jose, California, USA.
BGI Group (China) · CNComplete Genomics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleic acid ligases are crucial enzymes that repair breaks in DNA or RNA during synthesis, repair and recombination. Various genomic tools have been developed using the diverse activities of DNA/RNA ligases. Herein, we demonstrate a non-conventional ability of T4 DNA ligase to insert 5' phosphorylated blunt-end double-stranded DNA to DNA breaks at 3'-recessive ends, gaps, or nicks to form a Y-shaped 3'-branch structure. Therefore, this base pairing-independent ligation is termed 3'-branch ligation (3'BL). In an extensive study of optimal ligation conditions, the presence of 10% PEG-8000 in the ligation buffer significantly increased ligation efficiency to more than 80%. Ligation efficiency was slightly varied between different donor and acceptor sequences. More interestingly, we discovered that T4 DNA ligase efficiently ligated DNA to the 3'-recessed end of RNA, not to that of DNA, in a DNA/RNA hybrid, suggesting a ternary complex formation preference of T4 DNA ligase. These novel properties of T4 DNA ligase can be utilized as a broad molecular technique in many important genomic applications, such as 3'-end labelling by adding a universal sequence; directional tagmentation for NGS library construction that achieve theoretical 100% template usage; and targeted RNA NGS libraries with mitigated structure-based bias and adapter dimer problems.

Indexed as

DNADNA LigasesGenetic EngineeringHigh-Throughput Nucleotide SequencingHumansRNADNADNA LigasesRNAmolecular toolNGSnovel ligationT4 DNA ligase

Identifiers

PMID30428014
PMCPMC6379041
OpenAlexW2950782725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.